Q1 2022 Holdings
Filed 2022-05-20 | 70 holdings | $443.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amgen Inc COM(AMGN) | COM | 031162100 | $32.6K | 66,746 | 7.3% |
| Prothena Corp PLC Usd0.01(PRTA) | SHS | G72800108 | $23.8K | 15,000 | 5.4% |
| Alnylam Pharms.(ALNY) | COM | 02043Q107 | $21.7K | 38,000 | 4.9% |
| Intra-Cellular Therapies(ITCIEUR) | COM | 46116X101 | $20.9K | 50,956 | 4.7% |
| Harmony Biosciences Hldgs(HRMY) | COM | 413197104 | $20.5K | 205,474 | 4.6% |
| Biocryst Pharms.(BCRX) | COM | 09058V103 | $19.3K | 57,000 | 4.3% |
| Novavax(NVAX) | COM NEW | 670002401 | $18.5K | 132,500 | 4.2% |
| Rocket Pharms.(RCKT) | COM | 77313F106 | $17.9K | 63,000 | 4.0% |
| Supernus Pharms.(SUPN) | COM | 868459108 | $17.5K | 297,500 | 3.9% |
| Zai Lab Ltd ADR (V1 Ord)(ZLAB) | ADR | 98887Q104 | $17.0K | 78,958 | 3.8% |
| Insmed(INSM) | COM | 457669307 | $14.3K | 40,100 | 3.2% |
| Uniqure B V Eur0.05(QURE) | SHS | N90064101 | $11.8K | 155,500 | 2.7% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $11.6K | 190,749 | 2.6% |
| Beigene ADR(ONC) | Sponsored ADR | 07725L102 | $11.4K | 15,700 | 2.6% |
| Kalvista Pharms.(KALV) | COM | 483497103 | $10.8K | 383,233 | 2.4% |
| Illumina(ILMN) | COM | 452327109 | $10.8K | 48,000 | 2.4% |
| Hutchmed China Ltd Adr(v0.5 Ord)(HCM) | SPONSORED ADS | 44842L103 | $10.1K | 68,000 | 2.3% |
| Gamida Cell Ltd COM Usd0.01 | SHS | M47364100 | $10.0K | 107,000 | 2.3% |
| Biohaven Pharm. Hldg.(BHVN) | COM | G11196105 | $9.3K | 130,900 | 2.1% |
| Turning Point Therapeutic | COM | 90041T108 | $8.7K | 14,093 | 2.0% |
| Denali Therapeutics(DNLI) | COM | 24823R105 | $8.2K | 38,000 | 1.8% |
| Avadel Pharms. | sponsored ADR | 05337M104 | $7.6K | 50,000 | 1.7% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $7.6K | 31,500 | 1.7% |
| Horizon Therapeutics | SHS | G4617B105 | $7.5K | 183,473 | 1.7% |
| Jazz Pharms.(JAZZ) | SHS USD | G50871105 | $5.9K | 17,200 | 1.3% |
| Fate Therapeutics(FATE) | COM | 31189P102 | $5.6K | 28,000 | 1.3% |
| Legend Biotech(LEGN) | SPONSORED ADS | 52490G102 | $5.6K | 4,500 | 1.3% |
| Axsome Therapeutics(AXSM) | COM | 05464T104 | $5.4K | 14,000 | 1.2% |
| Madrigal Pharms.(MDGL) | COM | 558868105 | $5.1K | 5,350 | 1.1% |
| Chinook Therapeutics(290A) | COM | 16961L106 | $4.7K | 340,389 | 1.1% |
| Aurinia Pharmaceuticals Inc Com NPV(AUPH) | COM | 05156V102 | $4.0K | 435,000 | 0.9% |
| Ionis Pharms.(IONS) | COM | 462222100 | $3.3K | 154,088 | 0.7% |
| Vertex Pharms.(VRTX) | COM | 92532F100 | $3.2K | 25,122 | 0.7% |
| Xenon Pharmaceuticals Inc NPV(XENE) | COM | 98420N105 | $3.2K | 25,500 | 0.7% |
| Neurocrine Biosciences(NBIX) | COM | 64125C109 | $3.1K | 203,000 | 0.7% |
| Utd. Therapeutics(UTHR) | COM | 91307C102 | $2.9K | 20,000 | 0.7% |
| Iovance Biotherapeutics(IOVA) | COM | 462260100 | $2.8K | 58,000 | 0.6% |
| Harpoon Therapeutics | COM | 41358P106 | $2.8K | 151,445 | 0.6% |
| Incyte(INCY) | COM | 45337C102 | $2.6K | 238,000 | 0.6% |
| I-Mab(NBP) | SPONSORED ADS | 44975P103 | $2.4K | 18,000 | 0.5% |
| Regeneron Pharms.(REGN) | COM | 75886F107 | $2.2K | 12,100 | 0.5% |
| Black Diamond Therapeutic | COM | 0920E3105 | $2.1K | 44,000 | 0.5% |
| Ultragenyx Pharm.(RARE) | COM | 90400D108 | $2.1K | 233,100 | 0.5% |
| Ascendis Pharma ADR(ASND) | Sponsored ADR | 04351P101 | $2.0K | 29,400 | 0.4% |
| Gbl. Blood Therapeutics | COM | 37890U108 | $1.6K | 151,800 | 0.4% |
| Ideaya Biosciences(IDYA) | COM | 45166A102 | $1.6K | 109,000 | 0.4% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $1.6K | 380,000 | 0.3% |
| Apellis Pharms.(APLS) | COM | 03753U106 | $1.5K | 32,500 | 0.3% |
| Springworks Therapeutics | COM | 85205L107 | $1.4K | 16,300 | 0.3% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $1.4K | 188,500 | 0.3% |